These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils. Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890 [TBL] [Abstract][Full Text] [Related]
3. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro. Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583 [TBL] [Abstract][Full Text] [Related]
5. Evidence that the eosinophil is a cellular target for the inhibitory action of salmeterol on eosinophil recruitment in vivo. Teixeira MM; Hellewell PG Eur J Pharmacol; 1997 Apr; 323(2-3):255-60. PubMed ID: 9128847 [TBL] [Abstract][Full Text] [Related]
6. Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils. Kaneko T; Alvarez R; Ueki IF; Nadel JA Cell Signal; 1995 Jul; 7(5):527-34. PubMed ID: 8562314 [TBL] [Abstract][Full Text] [Related]
8. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram. Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the inhibitory activity of selective PDE4 inhibitors on eosinophil recruitment in guinea pig skin. Teixeira MM; Miotla JM; Cooper N; Gristwood RW; Hellewell PG Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():193-6. PubMed ID: 9698932 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Hatzelmann A; Tenor H; Schudt C Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697 [TBL] [Abstract][Full Text] [Related]
11. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils. Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060 [TBL] [Abstract][Full Text] [Related]
12. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol. Au BT; Teixeira MM; Collins PD; Williams TJ Br J Pharmacol; 1998 Mar; 123(6):1260-6. PubMed ID: 9559913 [TBL] [Abstract][Full Text] [Related]
13. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol. Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. Underwood DC; Osborn RR; Novak LB; Matthews JK; Newsholme SJ; Undem BJ; Hand JM; Torphy TJ J Pharmacol Exp Ther; 1993 Jul; 266(1):306-13. PubMed ID: 8392555 [TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633. Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Raeburn D; Underwood SL; Lewis SA; Woodman VR; Battram CH; Tomkinson A; Sharma S; Jordan R; Souness JE; Webber SE Br J Pharmacol; 1994 Dec; 113(4):1423-31. PubMed ID: 7889300 [TBL] [Abstract][Full Text] [Related]
17. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4. Blease K; Burke-Gaffney A; Hellewell PG Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364 [TBL] [Abstract][Full Text] [Related]
18. Desensitization of beta2-adrenoceptor and hypersensitization to phosphodiesterase inhibitors elicited by beta2-agonists in guinea pig eosinophils. Mio M; Kirino Y; Kamei C J Allergy Clin Immunol; 2000 Nov; 106(5):896-903. PubMed ID: 11080712 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo. Cooper N; Teixeira MM; Warneck J; Miotla JM; Wills RE; Macari DM; Gristwood RW; Hellewell PG Br J Pharmacol; 1999 Apr; 126(8):1863-71. PubMed ID: 10372831 [TBL] [Abstract][Full Text] [Related]
20. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone. Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]